8-K: BioCardia Clarifies Conference Call Time for CardiAMP-HF Two-Year Results

BioCardia, Inc. clarifies the timing of its conference call to discuss the two-year results of the CardiAMP-HF study, scheduled for today, March 31, 2025, at 4:30 PM EDT.

Summary

• BioCardia, Inc. issued a press release on March 31, 2025, to clarify the time of its conference call regarding the two-year results of the CardiAMP-HF study.
• The conference call is scheduled for today, March 31, 2025, at 4:30 PM EDT.
• Participants can register for the conference call online to receive a dial-in number.
• Alternatively, interested parties can dial in using the provided U.S. and international phone numbers, using access code 6220156.
• A live webcast and replay will be available through the provided links.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily provides logistical information about a conference call. It doesn't contain overtly positive or negative information.

Positives

• BioCardia is providing multiple avenues for stakeholders to access the conference call, including registration, phone dial-in, and live webcast.
• A replay of the conference call will be available shortly after the live event.

Future Outlook

The document announces a conference call to discuss the two-year results of the CardiAMP-HF study, suggesting that the company will be providing updates on the progress and potential future of this therapeutic program.

Industry Context

BioCardia is a player in the cellular and cell-derived therapeutics space, specifically targeting cardiovascular and pulmonary diseases. This announcement relates to the progress of their CardiAMP-HF study, which is relevant to the broader field of regenerative medicine and cardiac therapies.

Stakeholder Impact

• Shareholders will be interested in the results of the CardiAMP-HF study.
• Investors will be keen to understand the implications of the study results for BioCardia's future prospects.
• The medical community will be interested in the potential of CardiAMP-HF as a treatment for cardiovascular diseases.

Next Steps

• Attend or listen to the BioCardia conference call on March 31, 2025, at 4:30 PM EDT.
• Review the webcast replay of the conference call.

Key Dates

Keywords

BioCardia, CardiAMP-HF, conference call, results, cardiovascular, pulmonary, therapeutics